3.00p+0.00 (+0.00%)28 Mar 2024, 15:40
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Allergy Therapeutics PLC Fundamentals

Company NameAllergy Therapeutics PLCLast Updated2024-03-28
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue4.766 bnMarket Cap£142.99 m
PE Ratio49.50Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.06EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1426Debt Equity Ratio0.3061
Asset Equity Ratio2.6104Cash Equity Ratio0.5110
Quick Ratio0.9281Current Ratio1.40
Price To Book Value5.4025ROCE0

Allergy Therapeutics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Allergy Therapeutics PLC Company Financials

Assets202320222021
Tangible Assets£23.24 m£20.19 m£19.72 m
Intangible Assets£5.14 m£5.04 m£4.75 m
Investments000
Total Fixed Assets£33.24 m£30.55 m£30.23 m
Stocks£11.59 m£11.41 m£10.84 m
Debtors£6.55 m£9.21 m£5.78 m
Cash & Equivalents£14.64 m£20.32 m£40.07 m
Other Assets000
Total Assets£66.77 m£72.95 m£88.09 m
Liabilities202320222021
Creditors within 1 year£18.57 m£18.05 m£18.23 m
Creditors after 1 year£46.14 m£17.13 m£21.32 m
Other Liabilities000
Total Liabilities£64.70 m£35.18 m£39.55 m
Net assets£2.07 m£37.77 m£48.53 m
Equity202320222021
Called up share capital£679,000.00£644,000.00£641,000.00
Share Premium£119.03 m£112.58 m£112.58 m
Profit / Loss-£41.77 m-£12.66 m£3.66 m
Other Equity£2.07 m£37.77 m£48.53 m
Preference & Minorities000
Total Capital Employed£2.07 m£37.77 m£48.53 m
Ratios202320222021
Debt Ratio£0.94£0.18£0.16
Debt-to-Equity£16.55£0.22£0.19
Assets / Equity2.61042.61042.6104
Cash / Equity0.51100.51100.5110
EPS-£0.06-£0.02£0.00
Cash Flow202320222021
Cash from operating activities-£28.88 m-£14.00 m£8.59 m
Cashflow before financing-£1.08 m-£16.81 m£6.37 m
Increase in Cash-£5.67 m-£19.80 m£3.73 m
Income202320222021
Turnover£59.59 m£72.77 m£84.33 m
Cost of sales£26.34 m£23.26 m£22.11 m
Gross Profit£33.24 m£49.51 m£62.23 m
Operating Profit-£39.65 m-£12.24 m£4.03 m
Pre-Tax profit-£41.77 m-£12.66 m£3.66 m

Allergy Therapeutics PLC Company Background

SectorHealthcare
ActivitiesAllergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
Latest Interim Date27 Mar 2024
Latest Fiscal Year End Date27 Sep 2023

Allergy Therapeutics PLC Directors

AppointedNamePosition
2024-01-30Dr. Babatunde Adekunle Otulana Non-Executive Director,Senior Independent Director
2024-01-30Mr. Peter Sinclair JensenNon-Executive Director,Chairman
2014-10-08Mr. Alejandro Esteban Manieu Weinstein JrNon-Executive Director
2011-10-21Dr. Thomas Alexander Hungerford HoldichExecutive Director,RandD Director
2011-10-21Dr. Christian GratzExecutive Director,Market Operations Director
2016-09-26Mr. Ian David PostlethwaiteExecutive Director,Finance Director and Company Secretary
2012-06-29Ms. Ignace Robert Agnes GoethalsNon-Executive Director
2021-11-22Mr. Stephen Rushworth SmithNon-Executive Director,Senior Independent Director
2024-01-30Mr. Manuel LlobetExecutive Director,Chief Executive Officer
2012-06-29Dr. Virinder NohriaNon-Executive Director
2011-10-21Mr. Keith Iain CarterNon-Executive Director
2022-05-26Mr. Nicolas Alexander Ulrich WykemanExecutive Director,Chief Financial Officer
2024-01-30Mr. Zheqing ShenNon-Executive Director
2024-01-30Mr. Anthony Michael ParkerNon-Executive Director

Allergy Therapeutics PLC Contact Details

Company NameAllergy Therapeutics PLC
AddressDominion Way, Worthing, BN14 8SA
Telephone+44 1903844700
Websitehttps://www.allergytherapeutics.com

Allergy Therapeutics PLC Advisors

Financial PR AdviserConsilium Strategic Communications
Phone+44 2037095700
SolicitorCooley LLP
Phone+44 2075834055
Fax+44 2077859355
Nominated AdviserPanmure Gordon (UK) Ltd
Phone+44 2078862500
StockbrokerPanmure Gordon (UK) Ltd
Phone+44 2078862500
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
SolicitorCovington & Burling LLP
Phone+44 2070672000
Fax +44 2070672222
AuditorGrant Thornton UK LLP
Phone+44 1293554130
Fax+44 1293554135
BankRoyal Bank of Scotland PLC